Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 7, 2008, Pages 3115-3120

  Keane, Pearse A ^a   Liakopoulos, Sandra ^a,b   Ongchin, Sharel C ^a   Heussen, Florian M ^a   Msutta, Sandeep ^a   Chang, Karen T ^a   Walsh, Alexander C ^a   Sadda, Srinivas R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; B SCAN; CLINICAL TRIAL; COMPUTER PROGRAM; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL FLUID; TACHYPHYLAXIS; VISUAL ACUITY; BODY FLUID; COMPUTER ASSISTED DIAGNOSIS; DRUG EFFECT; METABOLISM; MIDDLE AGED; PAPILLEDEMA; PATHOLOGY; RETINA; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TIME;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BODY FLUIDS; CHOROIDAL NEOVASCULARIZATION; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PAPILLEDEMA; PIGMENT EPITHELIUM OF EYE; RETINA; RETINAL DETACHMENT; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 48249144751     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1689     Document Type: Article

References (16)

1. Bressler NM, Bressler SB, Congdon NG, et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol. 2003;121:1621-1624. (Pubitemid 37392370)
2. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137:486-495. (Pubitemid 38328641)
3. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol. 1991;109:1220-1231.
4. Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporphin: fluorescein angiographic guidelines for evaluation and treatment - TAP and VIP report no. 2. Arch Ophthalmol. 2003;121:1253-1268.
5. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR, Group VISiONCT. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816. (Pubitemid 40051904)
6. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431. (Pubitemid 44511557)
7. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006;113:363-372.e365. (Pubitemid 43296975)
8. Kaiser PK, Blodi BA, Shapiro H, Acharya NR. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114:1868-1875. (Pubitemid 47483925)
9. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566-583. (Pubitemid 46452533)
10. Hee MR. Artifacts in optical coherence tomography topographic maps. Am J Ophthalmol. 2005;139:154-155. (Pubitemid 40094854)
11. Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol. 2005;139:18-29. (Pubitemid 40094836)
12. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology. 2006;113:285-293. (Pubitemid 43170778)
13. Sadda SR, Joeres S, Wu Z, et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. Invest Ophthalmol Vis Sci. 2007;48:839-848. (Pubitemid 351260721)
14. Joeres S, Tsong JW, Updike PG, et al. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:4300-4307. (Pubitemid 351261062)
15. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporphin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444. (Pubitemid 44511558)
16. Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol. 2007;52:227-243. (Pubitemid 46654138)